5. Investigator, “Outcome Assessment in case of Severe COVID-19 Patients Treated with Remdesivir”, supported by Khulna Medical College Hospital, 2020

Short Description:

The objective of this study was to assess the outcome of hospitalised severe COVID-19 patients treated with Remdesivir. The research answered the research question: (a) How does remdesivir affect the outcome in terms of recovery and reducing mortality? (b) What is the superiority of remdesivir in the treatment of COVID-19 patients in comparison to other supportive treatments? (c) Can we recommend remdesivir as a first-line antiviral agent against novel coronavirus?

4. Investigator, “Efficacy of Favipiravir in treating hospitalized COVID- 19 patients: A Randomized, Controlled, Double-Blind Clinical Trial”, supported by Khulna Medical College Hospital, 2020

Short Description:

The objective of the study was to assess the efficacy of favipiravir on a greater scale in the treatment of hospitalised COVID-19 patients. The research answered the research question: (a) What is the superiority of favipiravir in the treatment of COVID-19 patients in comparison to other supportive treatments? (b) Can we recommend favipiravir as a first-line antiviral agent against novel coronavirus? (c) How does favipiravir affect the outcome in terms of recovery and reducing mortality?

3. Research Protocol titled “Prevalence of Unrecognized Diabetes Mellitus, Impaired Glucose Tolerance & Impaired Fasting Glucose among patients of Acute Coronary Syndrome in a Tertiary Level Hospital” under the fellow of the Bangladesh College of Physicians and Surgeons (FCPS), 2020

Short Description:

The objective of the study was to investigate the prevalence of unrecognized Diabetes Mellitus, Impaired Glucose Tolerance and Impaired Fasting Glucose among patients admitted with Acute Coronary Syndrome in a tertiary level hospital. Specific objectives were to diagnose Acute Coronary Syndrome in patients with chest pain and to find out the association of Diabetes Mellitus, Impaired Glucose Tolerance, and Impaired Fasting Glucose among these patients. The research question was: (a) What is the prevalence of unrecognized Diabetes Mellitus, Impaired Glucose Tolerance and Impaired Fasting Glucose among patients with Acute Coronary Syndrome in a tertiary level hospital?

2. Co-investigator, “Why NGOs are good at providing health service to the poor? Learning from NGO approach to health service provision in Bangladesh”, supported by Leprosy Mission International Bangladesh, conducted by Khulna University of Engineering & Technology (KUET), 2020

Short Description:

The objective of this study was to see whether NGOs and missionaries of charity are better than the public and private charity sectors in providing health services. The research answered the research questions: (a) What are the commonalities of treatment among the public, NGO/missionaries of charities and private charity? (b) Do people prefer NGOs/missionaries of charities for socially taboo diseases? (c) What are the positives of public, NGO/missionaries of charities and private charity? (d) Can the three sectors complement each other through co-learning and sharing of resources?

1. Physician, in the project of Encephalitis Surveillance, a Joint Project of Center for Disease Control of America (CDC) and ICDDR, B from June 2017 to December 2018

Short Description:

Hospital-based surveillance Aetiology of encephalitis that involved the questionnaire survey, pathological investigation, and postmortem lung and brain biopsy in collaboration with ICDDR, B and CDC Atlanta. This project mainly focused on the incidence of Nipah encephalitis among clinically suspected Encephalitis admitted to Khulna Medical College Hospital.

4. Morshed, M. M., Khanom, T. (2021). Comparing NGOs and Public Health Services Treating Leprosy and Tuberculosis in a City of Bangladesh, Bangladesh Journal of Infectious Diseases, 8(2), 71-74, DOI: https://doi.org/10.3329/bjid.v8i2.59632

3. Biswas, S. B., Ballav, S. K., Ahmed, S. F. U., Chandra, U., Khanom, T., Haque, M., Roy, R., & Mridha, A. K. (2021). Outcome Assessment in Case of Severe COVID-19 Patients Treated with Remdesivir. Global Journal of Medical Research: K Interdisciplinary, 7(21), 1-18.

2. Biswas, S. B., Ballav, S. K., Ahmed, S. F. U., Monir-Uz-Zaman, M., Chandra, U., Khanom, T., Haque, M., Roy, R., & Mridha, A. K. (2021). Efficacy of Favipiravir in Treating Hospitalized Covid-19 Patients: A Randomized, Controlled, Double-Blind Clinical Trial. European Journal of Pharmaceutical and Medical Research, 8(9), 862-869.

1. Das, B. K., Sarder, A. H., Khanom, T., Shaikh, M. S. A., & Islam, M. S. (2020). Variation of electrolyte status in relation to the type of acute stroke patients. Bangladesh Medical Journal Khulna, 52 (1-2), 12–15. https://doi.org/10.3329/bmjk.v52i1-2.461422